Background Immune system activation with associated up-regulation in the production of extra-cellular matrix proteins by fibroblasts are known specific features in the pathogenesis of systemic scleroderma (SSc). Most recent data indicate that MCP-1 and MCP-3 chemokines from the family of monocyte chemoattractant proteins are also involved into SSc pathogenetic process. C-reactive protein (CRP) is known as the marker of acute-phase inflammation. The association between increased CRP levels and SSc clinical and serological parameters has been reported recently.
Objectives To study the association between -2518 A/G gene polymorphism, encoding MCP-1, and CRP levels in different clinical SSc phenotypes in the Russian cohort of pts.
Methods PCR-RFLP method was used to identify MCP-1 genotype in 81 SSc pts aged 49,4±12,6 years, with mean SSc duration 11,1±9,0 years. CRP concentrations were measured with highly sensitive immunoturbidimertry method.
Results CRP levels were correlated with MCP-1 genotypes in pts with limited (lcSSc) and diffuse (dcSSc) phenotypes, with interstitial lung disease (ILD+), with SSc duration >3 years, with increased CRP level (>5 mg/L), with positive antibody titers to DNA topoisomerase I (ATA+) and antibody to centromeres (ACA+). A total cohort analysis showed that carriers of -2518AA genotype had higher mean CRP level versus G allele carriers (12,6±7,5 mg/L vs 4,9±4,8 mg/L, respectively, p=0,009), although similar trend was found in dcSSc phenotype (16,4±19,5 mg/L vs 6,1±4,4 mg/L, respectively, p=0,040). In pts with -2518AA genotype and SSc duration >3 years mean CRP level was significantly higher than in G allele carriers (1,1±16,7 mg/L vs 4,5±4,4 mg/L, respectively, p=0,025). In (ILD+) and (ATA+) subgroup pts with -2518AA genotype demonstrated higher mean CRP levels as compared to G allele carriers (12,4±15,6 mg/L vs 5,5±5,1 mg/L, respectively, p=0,018; and 17,6±20,9 mg/L vs 5,5±5,5 mg/L, respectively, p=0,010). CRP levels (>5 mg/L) were found in 31 (38%) pts and were significantly different between AA genotype carriers and G allele carriers (27,4±19,2 mg/L vs 10,4±3,8 mg/L, respectively, p=0,003). No associations between genetic variations in the MCP-1 gene and CRP levels in lcSSc phenotype, SSc duration <3 years, CRP levels <5mg/L and (ACA+) pts were established.
Conclusions Our data demonstrate that -2518A/G MCP-1 gene polymorphism is closely associated with CRP levels, thus, it can be considered as a new marker, reflecting the severity of the disease and unfavorable SSc prognosis.
Disclosure of Interest None declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.